248 related articles for article (PubMed ID: 24028560)
1. Coxiella burnetii exploits host cAMP-dependent protein kinase signalling to promote macrophage survival.
Macdonald LJ; Graham JG; Kurten RC; Voth DE
Cell Microbiol; 2014 Jan; 16(1):146-59. PubMed ID: 24028560
[TBL] [Abstract][Full Text] [Related]
2. Coxiella burnetii alters cyclic AMP-dependent protein kinase signaling during growth in macrophages.
MacDonald LJ; Kurten RC; Voth DE
Infect Immun; 2012 Jun; 80(6):1980-6. PubMed ID: 22473604
[TBL] [Abstract][Full Text] [Related]
3. Vasodilator-Stimulated Phosphoprotein Activity Is Required for Coxiella burnetii Growth in Human Macrophages.
Colonne PM; Winchell CG; Graham JG; Onyilagha FI; MacDonald LJ; Doeppler HR; Storz P; Kurten RC; Beare PA; Heinzen RA; Voth DE
PLoS Pathog; 2016 Oct; 12(10):e1005915. PubMed ID: 27711191
[TBL] [Abstract][Full Text] [Related]
4. Coxiella burnetii Requires Host Eukaryotic Initiation Factor 2α Activity for Efficient Intracellular Replication.
Brann KR; Fullerton MS; Voth DE
Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32284364
[No Abstract] [Full Text] [Related]
5. Coxiella burnetii type IV secretion-dependent recruitment of macrophage autophagosomes.
Winchell CG; Graham JG; Kurten RC; Voth DE
Infect Immun; 2014 Jun; 82(6):2229-38. PubMed ID: 24643534
[TBL] [Abstract][Full Text] [Related]
6. Coxiella burnetii effector proteins that localize to the parasitophorous vacuole membrane promote intracellular replication.
Larson CL; Beare PA; Voth DE; Howe D; Cockrell DC; Bastidas RJ; Valdivia RH; Heinzen RA
Infect Immun; 2015 Feb; 83(2):661-70. PubMed ID: 25422265
[TBL] [Abstract][Full Text] [Related]
7. Virulent Coxiella burnetii pathotypes productively infect primary human alveolar macrophages.
Graham JG; MacDonald LJ; Hussain SK; Sharma UM; Kurten RC; Voth DE
Cell Microbiol; 2013 Jun; 15(6):1012-25. PubMed ID: 23279051
[TBL] [Abstract][Full Text] [Related]
8. Effector protein translocation by the Coxiella burnetii Dot/Icm type IV secretion system requires endocytic maturation of the pathogen-occupied vacuole.
Newton HJ; McDonough JA; Roy CR
PLoS One; 2013; 8(1):e54566. PubMed ID: 23349930
[TBL] [Abstract][Full Text] [Related]
9. Coxiella burnetii as a useful tool to investigate bacteria-friendly host cell compartments.
Pechstein J; Schulze-Luehrmann J; Lührmann A
Int J Med Microbiol; 2018 Jan; 308(1):77-83. PubMed ID: 28935173
[TBL] [Abstract][Full Text] [Related]
10.
Mahapatra S; Gallaher B; Smith SC; Graham JG; Voth DE; Shaw EI
Front Cell Infect Microbiol; 2016; 6():188. PubMed ID: 28066723
[No Abstract] [Full Text] [Related]
11. Dependency of
Larson CL; Beare PA; Heinzen RA
J Bacteriol; 2019 Dec; 201(23):. PubMed ID: 31501284
[TBL] [Abstract][Full Text] [Related]
12. Identification of ElpA, a Coxiella burnetii pathotype-specific Dot/Icm type IV secretion system substrate.
Graham JG; Winchell CG; Sharma UM; Voth DE
Infect Immun; 2015 Mar; 83(3):1190-8. PubMed ID: 25605765
[TBL] [Abstract][Full Text] [Related]
13. The Coxiella burnetii T4SS effector protein AnkG hijacks the 7SK small nuclear ribonucleoprotein complex for reprogramming host cell transcription.
Cordsmeier A; Rinkel S; Jeninga M; Schulze-Luehrmann J; Ölke M; Schmid B; Hasler D; Meister G; Häcker G; Petter M; Beare PA; Lührmann A
PLoS Pathog; 2022 Feb; 18(2):e1010266. PubMed ID: 35134097
[TBL] [Abstract][Full Text] [Related]
14. Dot/Icm type IVB secretion system requirements for Coxiella burnetii growth in human macrophages.
Beare PA; Gilk SD; Larson CL; Hill J; Stead CM; Omsland A; Cockrell DC; Howe D; Voth DE; Heinzen RA
mBio; 2011; 2(4):e00175-11. PubMed ID: 21862628
[TBL] [Abstract][Full Text] [Related]
15. Sustained activation of Akt and Erk1/2 is required for Coxiella burnetii antiapoptotic activity.
Voth DE; Heinzen RA
Infect Immun; 2009 Jan; 77(1):205-13. PubMed ID: 18981248
[TBL] [Abstract][Full Text] [Related]
16. Host pathways important for Coxiella burnetii infection revealed by genome-wide RNA interference screening.
McDonough JA; Newton HJ; Klum S; Swiss R; Agaisse H; Roy CR
mBio; 2013 Jan; 4(1):e00606-12. PubMed ID: 23362322
[TBL] [Abstract][Full Text] [Related]
17. Noncanonical Inhibition of mTORC1 by Coxiella burnetii Promotes Replication within a Phagolysosome-Like Vacuole.
Larson CL; Sandoz KM; Cockrell DC; Heinzen RA
mBio; 2019 Feb; 10(1):. PubMed ID: 30723133
[TBL] [Abstract][Full Text] [Related]
18. The Coxiella burnetii Dot/Icm system creates a comfortable home through lysosomal renovation.
Newton HJ; Roy CR
mBio; 2011; 2(5):. PubMed ID: 22010216
[TBL] [Abstract][Full Text] [Related]
19. The Coxiella burnetii Dot/Icm system delivers a unique repertoire of type IV effectors into host cells and is required for intracellular replication.
Carey KL; Newton HJ; Lührmann A; Roy CR
PLoS Pathog; 2011 May; 7(5):e1002056. PubMed ID: 21637816
[TBL] [Abstract][Full Text] [Related]
20. Dot/Icm-Translocated Proteins Important for Biogenesis of the Coxiella burnetii-Containing Vacuole Identified by Screening of an Effector Mutant Sublibrary.
Crabill E; Schofield WB; Newton HJ; Goodman AL; Roy CR
Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29339460
[No Abstract] [Full Text] [Related]
[Next] [New Search]
